ALPS Advisors’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-57,035
| Closed | -$7.99M | – | 1057 |
|
|
2018
Q4 | $7.99M | Buy |
57,035
+3,114
| +6% | +$436K | 0.06% | 128 |
|
|
2018
Q3 | $9.21M | Buy |
53,921
+10,483
| +24% | +$1.79M | 0.06% | 124 |
|
|
2018
Q2 | $7.54M | Buy |
43,438
+3,399
| +8% | +$590K | 0.05% | 133 |
|
|
2018
Q1 | $4.62M | Buy |
40,039
+6,959
| +21% | +$803K | 0.04% | 154 |
|
|
2017
Q4 | $2.79M | Buy |
33,080
+3,679
| +13% | +$310K | 0.02% | 171 |
|
|
2017
Q3 | $2.71M | Buy |
29,401
+5,800
| +25% | +$534K | 0.02% | 171 |
|
|
2017
Q2 | $1.89M | Buy |
23,601
+1,623
| +7% | +$130K | 0.01% | 187 |
|
|
2017
Q1 | $925K | Buy |
21,978
+1,148
| +6% | +$48.3K | 0.01% | 225 |
|
|
2016
Q4 | $669K | Sell |
20,830
-6,788
| -25% | -$218K | ﹤0.01% | 249 |
|
|
2016
Q3 | $723K | Sell |
27,618
-2,397
| -8% | -$62.8K | 0.01% | 238 |
|
|
2016
Q2 | $696K | Buy |
30,015
+8,437
| +39% | +$196K | 0.01% | 218 |
|
|
2016
Q1 | $590K | Sell |
21,578
-3,698
| -15% | -$101K | 0.01% | 206 |
|
|
2015
Q4 | $719K | Buy |
+25,276
| New | +$719K | 0.01% | 234 |
|